emergency use authorisation

Brazil scraps Covaxin's EUA application after Bharat Biotech terminates pact with partners

The Brazilian health regulator's decision comesafter the vaccine maker informed the South American country about the termination of its pact with its partners in that country.

published on : 27th July 2021

Pfizer, Johnson and Johnson yet to apply for license of COVID-19 vaccines in India: Sources

Another giant pharma company Moderna is supposed to donate seven million doses to India from the United States under Covax is still pending.

published on : 15th July 2021

Zydus Cadila seeks emergency authorisation for ZyCoV-D COVID-19 vaccine for 12 years, above

The company's three-dose regimen Covid-19 vaccine is the second indigenously developed vaccine to apply for such permission after Bharat Biotech's Covaxin.

published on : 1st July 2021

India's first Covid vaccine for kids gets closer to reality, may get DGCI nod soon

ZyCoV-D, has been sent by pharmaceutical firm Zydus Cadila for emergency use authorisation to the DGCI after its clinical trials ended successfully in the country.

published on : 20th June 2021